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Suatu Perspektif Fungsi Spesifik Tapak Pemfosforilan Focal Adhesion Kinase 
Sebagai Penanda Prognostik dalam Kanser Payu Dara, Kolon, Hati dan 
Leukemia 
 
ABSTRAK 
 
Focal Adhesion Kinase (FAK) merupakan suatu protein kinase tirosin bukan reseptor 
bersaiz 125 kDa. FAK memainkan peranan penting dalam pengawalaturan pelbagai 
aktiviti sel seperti migrasi, perekatan, proliferasi dan pertumbuhan.  Dilaporkan 
bahawa FAK mempunyai dua fungsi, iaitu sebagai protein kerangka dan protein 
kinase. Analisis pada paras protein dan sel menunjukkan ekspresi FAK yang 
berlebihan dan pemfosforilan FAK pada residu khusus dalam kebanyakan tumor. 
Walau bagaimanapun, kebanyakan data ini masih kurang jelas dan memerlukan 
kajian lanjut. Dalam kajian ini, kami memeriksa total FAK dan pemfosforilan FAK 
pada pelbagai residu dalam sel kanser payu dara, kolon, hati dan leukemia. Di 
samping itu, kami juga membandingkannya dengan sel normal menggunakan analisis 
pemblotan Western dan analisis imunopendarflour. Kami mencadangkan bahawa 
tahap fosforilasi FAK yang tinggi pada Tyr 397 dan Tyr 861 sangat diperlukan dalam  
dalam sel kanser payu dara yang lebih invasif. Kami juga mendapati bahawa MDA-
MB-231, sel kanser payu dara yang tidak mengekspresikan reseptor estrogen, 
menunjukkan fosforilasi FAK yang tinggi pada Tyr 397 dan Tyr 861.  Ekspresi 
fosfo-FAK (Ser 910) yang tinggi dikesan dalam sel kanser payu dara yang kurang 
invasif (T-47D dan MCF-7) dibandingkan dengan MDA-MB-231 yang lebih invasif. 
Berkenaan dengan kanser kolon, kami mendapati sel kolon yang mengalami 
pembezaan yang sederhana dan kurang invasif, HT-29, menunjukkan tahap FAK 
yang lebih rendah dibandingkan dengan sel kanser kolon yang tidak membeza dan 
 xvi 
 
lebih invasif, HCT 116. Fosfo-FAK (Tyr 397) diekspresi dengan lebih tinggi dalam 
HT-29 berbanding HCT 116. Fosforilasi FAK pada Ser 910 dikesan dalam sel 
normal dan sel yang mengalami pembezaan, CCD-18Co dan HT-29 masing-masing, 
tetapi tidak dikesan dalam sel yang lebih agresif, HCT 116. Penemuan ini 
mencadangkan bahawa fosforilasi FAK pada dua residu tirosin (Tyr 397 dan Tyr 
861) mungkin suatu keperluan penting dalam memberikan ciri invasif kanser 
memandangkan aras yang tinggi diperhatikan dalam titisan sel yang lebih invasif. 
Berbeza dengan kanser payu dara, protein FAK mungkin diperlukan terutamanya 
dalam regulasi sel kolon normal dan sel kolon yang terbeza, seperti CCD-18Co dan 
HT-29 masing-masing. Fosforilasi FAK pada Ser 910 mungkin mempunyai kesan 
perencatan dalam kanser payu dara, memandangkan sel yang kurang invasif, T-47D 
menunjukkan aras fosforilasi yang lebih tinggi pada residu ini. Kedua-dua  Tyr 397 
dan Tyr 861 juga tidak terfosforilasi. Berdasarkan kajian kami, dicadangkan bahawa 
fosforilasi FAK pada Ser 910 mungkin memainkan peranan yang penting dalam 
mengekalkan sebahagian daripada sifat-sifat yang berkait dengan fenotaip normal 
dan fenotaip yang berbeza.   
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A Prospective Role of Specific Focal Adhesion Kinase Phosphorylation Sites as 
Prognostic Markers in Cancers of Breast, Colon, Liver and Leukaemia 
 
ABSTRACT 
 
Focal Adhesion Kinase (FAK) is a 125 kDa non-receptor protein tyrosine kinase. 
FAK plays a pivotal role in the regulation of various cellular activities such as 
migration, adhesion, proliferation and growth. It has been reported that FAK has dual 
function as a scaffold and kinase protein. Analyses at the protein and cellular levels 
have demonstrated FAK overexpression and phosphorylation at specific residues in 
many tumours; however the data were mostly inconclusive and need further 
investigation. In this study, we set out to examine total FAK and phosphorylated 
FAK at various residues in breast, colon, liver cancer and leukemic cell lines in 
comparison to normal cell lines using Western blotting and immunofluorescent 
analyses. We propose that higher levels of phosphorylated FAK at Tyr 397 and Tyr 
861 are highly required in the more invasive breast cancer. We also found that MDA-
MB-231, breast cancer cells negatively expressing oestrogen receptor, exhibited 
higher FAK phosphorylation at Tyr 397 and Tyr 861. Higher expression of phospho-
FAK Ser 910 was detected in the less invasive breast cancer cell lines, T-47D and 
MCF7, compared to the highly invasive MDA-MB-231. In regard to colon cancer, 
we found that moderately differentiated and less invasive colon cancer cell line, HT-
29, expressed lower FAK level compared to the un-differentiated and more invasive 
colon cancer cell line, HCT 116. Phospho-FAK Tyr 397 was more expressed in HT-
29 than in HCT 116. However, phosphorylation at Ser 910 was detected in normal 
and more differentiated cells, CCD-18Co and HT-29 respectively, but was 
undetectable in the more aggressive cells, HCT 116. These findings suggest that 
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FAK phosphorylation at the two tyrosine residues, Tyr 397 and Tyr 861, may 
indicate a crucial requirement of these sites of phosphorylation in breast cancer 
invasiveness, since higher levels were observed in the more invasive cell lines. 
Contrary to breast cancer, FAK protein may be mainly required in the regulation of 
normal and differentiation colon cells, such as CCD-18Co and HT-29 respectively. 
Phosphorylation of FAK at Ser 910 appeared to have an inhibitory effect in breast 
cancer, since the less invasive cells, T-47D showed a higher level of phosphorylation 
at this residue whereas, both Tyr 397 and Tyr 861, were not phosphorylated. Based 
on our study, it is suggested that FAK phosphorylation at Ser 910 may play an 
important in retaining some of the characteristics of normal and differentiated 
phenotypes. 
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CHAPTER ONE 
INTRODUCTION 
 
1.1 Cancer 
 
Cancer is a genetic disease happens as a result of several mutations that happen due 
to abnormalities in DNA sequence (Futreal et al., 2001). Usually, a mutation is 
followed by an accelerated cellular proliferation resulting in increasing mass of cells 
termed as tumour (Vogelstein & Kinzler, 1993). In the development of cancer, a cell 
undergoes a multistep process of events leading to producing a malignant cell. These 
events are involved in the suppression of tumour suppressor genes, activation of 
oncogens and DNA alterations (Choy et al., 2004). One of the leading causes of 
cancer deaths is metastasis. Tumour metastasis is the spread of tumours to local and 
distant places away from the initiating tumour. It has been shown that tumour cell 
obtained from metastatic tumour displayed increased capacities of migration and 
invasion (Jin & Varner, 2004).  
 
Cancer is mostly classified according to its organ, or cell type in which it starts. Also, 
it can be classified into wider categories, while the main categories are:  
 Carcinoma - cancer of epithelial cells which initiates in tissues or skin that 
line or cover body organs. 
 Sarcoma - cancer of the connective tissues, like cancer that begins in blood, 
muscle, bone, cartilage, fat, or other supportive or connective tissues. 
 Leukaemia - cancer that produces a large number of abnormal blood cells in 
blood generating tissue, such as bone marrow.  
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 Lymphoma and myeloma - cancers that develop from cells originated from 
immune system.  
 Central nervous system cancers - cancers that occur in tissues of central 
nervous system, such as brain and spinal cord (Montella et al., 2001; Reya et 
al., 2001; Bhowmick et al., 2004).  
 
It is postulated that cancer incidence is highly affected by the number of proliferating 
cells. Basically, cell proliferation depends on the number of dividing cells in addition 
to the rate of cell division in certain tissue (Albanes & Winick, 1988). 
 
1.2 Tyrosine Kinases and cell signalling 
 
Protein tyrosine kinases (PTKs) exhibit an important role in cancer signalling. PTKs 
transfer α-phosphate groups from ATP to tyrosine sites on signal transduction 
molecules in a process called phosphorylation. Usually, phosphorylation leads to 
switching various signalling pathways, and consequently stimulating cell 
proliferation, increasing cell migration capacity and prolonging survival. In addition, 
phosphorylation of tyrosine residues on signal transduction molecules serves to 
further activate PTKs and create binding sites for other cytoplasmic signalling 
molecules, such as phospho-tyrosine proteins and Src homology molecules 
(Olayioye et al., 2000; Demetri et al., 2002). 
 
Receptor and non receptor protein tyrosine kinase families (RPTK and NRPTK 
respectively) are the main classes of PTKs. NRPTKs are basic components of 
signalling cascades activated by RPTKs and by other cell surface receptors. NRPTKs 
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are deficient in receptor-like features like an extracellular ligand-binding domain and 
transmembrane-spanning region, and normally they are localized in the cell 
cytoplasm (Hubbard & Till, 2000; Vlahovic & Crawford, 2003; Tsygankov, 2003). 
NRPTK family include Focal adhesion kinase (FAK), Src, Janus kinases (Jaks), 
Abelson tyrosine kinase (Abl), acetate kinase (Ack), C-terminal Src kinase (Csk), 
fps/fes related kinase (Fer/Fes), fyn-related kinase (Frk), Spleen tyrosine kinase 
(Syk) and Tec. (Gu & Gu, 2003). Figure 1.1 shows the involvement of RPTKs and 
NRPTKs in signals transmission. Following growth factors binding to their 
receptors, NRPTKs dimerization induces their autophosphorylation and conveys 
messages downstream to cytoplasmic and nuclear targets. Therefore, NRPTKs work 
downstream to RPTKs as they integrate RPTKs to transmit signals from extracellular 
matrix (ECM) to cell cytoplasm.  
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Figure 1.1: Signalling through tyrosine kinases (Adapted from Kolibaba and 
Druker, 1997). 
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1.3 Focal Adhesion Kinase  
1.3.1 Focal Adhesion Kinase Discovery 
 
Focal adhesion kinase (FAK) is a 125 KDa non-receptor cytoplasmic protein tyrosine 
kinase. FAK is localized to focal adhesion plaques where cellular interactions with 
extracellular matrix proteins take place. It was implied that FAK exhibits a crucial 
role in modulating several cellular signalling pathways (Schaller, 1996; Beviglia et 
al., 2003). Two research groups headed by Steve Hanks, Jun-Lin Guan and Michael 
Schaller discovered FAK independently in 1992.  
 
Prior to FAK discovery, previous researches were conducted to examine the 
involvement of Src in cancer signalling. FAK was identified as a substrate of the 
viral Src oncogen, and was known to localize at cell adhesion contacts where 
integrins assemble (Mitra et al,. 2005). It was shown that many human tumours 
expressed activated Src, and relevant FAK activation was related to specific human 
diseases. FAK activation was proposed to happen exclusively as a result of cellular 
transformations. Following activation, FAK was thought to promote tyrosine 
activation of substrates such as paxillin, and amplify mitogen activated protein 
kinase (MAP kinase) signalling in transformed cells. However, FAK inhibition was 
unable to restore transformed cells original phenotypes (Schaller, 2001; McLean et 
al., 2005).  
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1.3.2 FAK Structure 
 
Figure 1.2 illustrates FAK linear structure. FAK is encoded by PTK2 genes in 
humans (Gabarra-Niecko et al., 2003). The encoded protein consists of three main 
domains, a non catalytic N-terminal domain, a central catalytic domain and a C-
terminal domain. C-terminal domain consists of the focal adhesion targeting (FAT) 
sequence (Mon et al., 2006). There are also docking sites for proteins with SH3 
domain, located between catalytic domain and FAT sequence (Parsons, 2003). The 
N-terminal domain of FAK shows strong homology with structurally conserved 
FERM domains, which are present in various families of structural proteins like talin 
and protein 4.1, ezrin-radixin-moesin (FERM), as well as in JAK family kinases (Sun 
et al., 2002). FERM domains were thought to mediate protein-protein interactions. 
Some binding partners of FAK-FERM domain have been reported, among others are 
β1 integrin and growth factor receptors (EGFR and PDGFR) (Sieg et al., 2000). The 
N-terminal domain was thought to direct FAK interaction to signalling proteins and 
integrins clusters to regulate its catalytic activity (Parsons et al., 2003). FERM 
domain-mediated interactions were also thought to have a role in the regulation of 
cell motility (Streblow et al., 2003). 
 
FAK tyrosine phosphorylation with subsequent activation was increased when FAK 
N-terminal domain was truncated. N-terminal domain truncation is followed by 
assembly of Src family of protein tyrosine kinases (PTKs), and binding of Src-SH2 
domains to FAK at Tyr 397. FAK N-terminal domain truncation was thought to 
initiate autophosphorylation at FAK Tyr 397 leading to successive FAK 
phosphorylation at other tyrosine residues. These events were thought to fully 
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activate FAK molecule (Lietha et al., 2007). Additionally, mutant cells with 
truncated N-terminal domain exhibited an increased level of cell migration (Schaller, 
2001).  
 
Previous report suggested a role of FAK N-terminal (FERM) domain in the 
suppression of p53 transcription, thus the FERM domain could have an anti-
apoptotic activity leading to increase cell survival (Mitra and Schlaepfer, 2006). On 
the other hand, the N- terminal domain was shown to induce cell adhesion loss 
followed by apoptosis. Figure 1.3 shows the possible role of FAK N-terminal domain 
in the induction of apoptosis through adhesion loss. The FERM domain appeared to 
be involved in FAK nucleocytoplasmic translocation, which may lead to cellular 
rounding, detachment and then proceeding in apoptosis.   
 
The FAK C-terminal domain has many proteins interaction sites through which FAK 
can be localized and directed to adhesion complex regions. Focal adhesion targeting 
domain (FAT) is a part of the FAK C-terminal region which binds to paxillin and 
talin proteins, and contributes to supporting FAK localization to focal adhesions 
(Martin et al., 2002). FAK-related-non-kinase domain (FRNK) an autonomously 
expressed C-terminal domain of FAK was thought to inhibit FAK kinase activity 
contributing to the inhibition of cell spreading as well as chemotactic and haptotactic 
migration (Hildebrand et al., 1993; Hildebrand et al., 1995). Besides that, it was 
implied that FRNK suppresses growth-factor-stimulated signals transduction to MAP 
kinase (Hauck et al., 2001; Taylor et al., 2001; Parson, 2003). 
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Figure 1.2: FAK linear structure showing major domains and sites of tyrosine 
phosphorylation (Adapted from Mon et al., 2006). 
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Figure 1.3: FAK-N terminal domain (FAK-NT) induced cell loss of adhesion 
followed by cell detachment and apoptosis (Adapted from Beviglia et al., 2003). 
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1.3.3 FAK Phosphorylation, Activation and Inhibition 
 
FAK tyrosine phosphorylation with subsequent activation leads to stimulations of 
cell adhesion, spreading, invasion and metastasis of cancer cells. Conversely, 
disrupting FAK association with ECM signalling molecules dephosphorylates FAK 
specifically at tyrosine residues, inhibits its activity and downregulates several 
cellular activities (Schwartz & Assoian, 2001; Hynes, 2002; Sawai et al., 2003).  
 
FAK-integrins association at focal adhesions causes Tyr 397 phosphorylation and 
recruits Src kinases leading to FAK phosphorylation at other residues. FAK 
phosphorylation at tyrosine residues is an essential event for FAK activation, cell 
attachment to the ECM, cell adhesion and cell proliferation. The phosphorylation of 
FAK tyrosine residues is followed by the phosphorylation of intracellular proteins, 
creation of binding sites for many signalling proteins (Vuori, 1998) and forming 
signalling complexes at the focal adhesion regions (Ma et al., 2001). 
Dephosphorylation of FAK tyrosine residues was reported to terminate FAK activity 
leading to inhibition of specific cellular activities such as migration, invasion and 
growth (Tamura et al., 1999; Schaller, 2001). FAK activation does not exclusively 
happen as a result of integrin clustering to focal adhesion plaques, instead, growth 
factors, neuropeptides and bioreactive lipids are known of activating FAK in 
integrin-independent manner (Sieg et al., 1999). FAK activation can also be 
stimulated by platelet derived growth factors (PDGF), and human growth factor 
(HGF) (Chen et al., 1998; Cospedal et al., 1999). FAK association with Grb2, PI3-
Kinase, and p130C signalling molecules enables it to work as a switchable adaptor 
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protein, situated at a cross junction, controlling different signalling pathways and 
regulating different cellular activities (Hauck et al., 2002; Beviglia et al,. 2003). 
 
Unlike tyrosine phosphorylation, serine phosphorylation appeared to have a negative 
regulatory effect on FAK. It was observed that serine phosphorylation is normally 
accompanied by deactivation and dephosphorylation of FAK tyrosine residues and 
FAK disassembly from signalling complexes (Yamakita et al., 1999). It was reported 
that mitotic cells or cells at the interphase stage of cell cycle expressed elevated 
levels of FAK phosphorylated at serine residues (Yamaguchi et al., 1997; Yamakita 
et al., 1999). Therefore, serine phosphorylation appeared to be involved in cell cycle 
progression while it may have a downregulatory function on tyrosine 
phosphorylation.   
 
Generally, FAK phosphorylation at different tyrosine residues has been associated 
with the development of various types of tumours (McLean et al., 2005). FAK Tyr 
397 which is located upstream of the kinase domain is important for supporting 
adhesion strength, and recruitment of signalling proteins following integrin binding 
(Michael et al., 2009). Tyr 397 was correlated with higher potencies of cellular 
migration, proliferation and apoptosis protection (Mon et al., 2006). FAK Tyr 397 
has been considered as the only autophosphorylation site on FAK and its 
phosphorylation initiated FAK phosphorylation at various residues. It has been 
thought that the phosphorylation of this site is critically required in integrin-mediated 
FAK signalling (Siesser & Hanks, 2006). The rest of tyrosine residues are thought to 
be phosphorylated following Src kinases binding to FAK through Src-SH2 binding 
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domain (Mon et al., 2006). For these reasons, autophosphorylation of FAK Tyr 397 
may be considered as the most important event in FAK activation. 
 
FAK association with Src proteins is required for FAK activation. Src binding is 
essential for N-terminal translocation from the catalytic domain. As a result of that, 
successive phosphorylations of Tyr 407, Tyr 576, Tyr 577, Tyr 861, and Tyr 925 
happen, leading to maximal FAK activation (Schaller, 2001; Mon et al,. 2006). 
Following FAK-Src binding, several signalling molecules will be recruited and 
activated. FAK association with Src will trigger signalling pathways output 
amplification leading to the stimulation of various cellular activities (Siesser & 
Hanks, 2006; Caron-Lormier & Berry, 2005).  
 
FAK Tyr 407 phosphorylation appeared to have a negative effect on cell adhesion, 
spreading, migration and proliferation (Jeon et al., 2007). Elevated levels of 
phospho-FAK Tyr 407 were observed when cells were grown under stress 
conditions, such as during serum starvation, cell cycle arrest and contact inhibition. 
FAK Tyr 397 phosphorylation was suppressed as a result of FAK Tyr 407 
phosphorylation, thus FAK Tyr 407 may negatively affect FAK kinase activity and 
reduce total FAK activation (Lim et al,. 2007). According to another research 
findings, concurrent activations of FAK, Tyr 407 and Tyr 397 residues were directly 
correlated with more differentiated colon tumour with less malignant status 
(Matkowskyj et al,. 2003). On the contrary, endothelial cells expressed elevated 
levels of phospho-FAK Tyr 407 following exposure to vascular endothelial growth 
factor. Therefore, FAK Tyr 407 could be involved in the transduction of vascular 
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endothelial growth factor signalling, as it stimulates recruitment of focal adhesion 
molecules with the increase of endothelial cells migration (Le Boeuf et al., 2004).  
 
FAK Tyr 861 role in cancer was more prominent in breast cancers than any other 
cancers, since there have been some studies correlating FAK Tyr 861 with breast 
cancer development. Previous study examined FAK, HER2 protein, phospho-Src Tyr 
215 and phospho-FAK Tyr 861 expressions using frozen tissue sections. Western 
blots analysis showed co-expressions of phospho-FAK Tyr 861 and HER2 proteins 
(Schmitz et al., 2005). This indicated the critical role of FAK phosphorylation 
especially at Tyr 861 in regulating cell signalling of human breast cancer. FAK Tyr 
861 activation was implicated in FAK-αvβ5 integrins association, and was thought to 
work downstream of Src kinases. Moreover, FAK Tyr 861 was implicated in 
triggering signalling pathways leading to vascular development and angiogenesis 
(Eliceiri et al., 2002).  
 
FAK Tyr 576 and Tyr 577 are located in the kinase domain. Phosphorylation of these 
tyrosine residues is highly required to attain optimum FAK kinase activity (Jacamo 
et al,. 2007). FAK Tyr 576 and Tyr 577 phosphorylations are important events for 
restoring autoinhibited conformational FAK activity resulting in increasing FAK 
phosphorylation (Cox et al,. 2006).  
 
FAK Tyr 925 phosphorylation creates binding site for Grb2 protein through focal 
adhesion targeting (FAT) sequence of the C-terminal domain, and was thought to 
have a role in cancer cell proliferation (Zhao & Guan, 2009). Besides that, FAK Tyr 
925 was implicated in the induction of Ras signal transduction pathway through 
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association with Src family kinases. Importantly, activation of Ras pathway was 
expected to happen independently of integrin clustering (Schlaepfer & Hunter, 
1996). Therefore Tyr 925 could be involved in the signal transduction pathway in 
integrin independent manner. 
 
Tyrosine dephosphorylation is as crucial as tyrosine phosphorylation in modulating 
events happening at focal adhesions. PTP-PEST is one of the important phosphatases 
secreted at the focal adhesions. Cells lacking of PTP-PEST exhibited a decrease in 
focal adhesions with migrational defects (Angers-Loustau et al., 1999), however, 
elevated levels of PTP-PEST resulted in impaired associations and phosphorylation 
of many focal contacts signalling proteins (Garton & Tonks, 1999). Therefore, PTP-
PEST is secreted in a proper balance, and it acts as a key regulator for focal adhesion 
molecules phosphorylation (Sastry et al., 2002). FAK inactivation can also happen 
by a tumour suppressor gene known as PTEN which inhibits FAK phosphorylation 
leading to FAK deactivation (Lipinski et al., 2003). 
 
1.3.4 FAK Signalling  
 
FAK has been involved in integrating and modulating signals of neuropeptides and 
oncogenes (Burridge & Chrzanowska-Wodnicka, 1996; Schaller, 1997), and in many 
cancers FAK downstream signalling was shown to work subsequently to integrins 
activation. Integrins rearrangements on cell surface alter cancer cells phenotypes 
with changes in cells signalling accompanied by FAK activation (Giancotti & 
Ruoslahti, 1999). However, according to Yano et al. (2004) FAK signalling could 
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not be directly involved in altered cellular signalling following integrins 
rearrangements.  
 
Past studies showed that some cellular inhibitory or regulatory cascades were 
inhibited when cells transformed to cancer cells. That led to the activation of various 
cellular functions such as migration, proliferation, growth and survival accompanied 
the stimulation of multiple signalling pathways. Many cellular activities were shown 
to be more activated in a variety of cancer cells compared to normal cells (Cox et al, 
2006; Madan et al., 2006). FAK has been acknowledged for a potential role in 
cancer, and has been contributed to tumourigenesis through the enhancement of 
different cellular activities (Mon et al., 2006). Previous reports have shown a direct 
relationship correlating FAK level of expression and cell proliferation, adhesion, 
migration and survival (Schlaepfer et al,. 1999; Hood & Cheresh, 2002). FAK 
central function in cancer cells was postulated when cellular viability and adhesion to 
the ECM were inhibited following FAK displacement from focal adhesions. FAK 
displacement with subsequent dephosphorylation happened when Focal adhesion 
kinase C-terminal domain (FAK-CD) was used as a negative regulator of FAK 
(Madan et al., 2006).  
 
1.3.5 FAK as a Scaffold and Src Stimulator Protein 
 
Recently, FAK has also been considered as a scaffold protein which has the 
capability of nucleating multivalent scaffold complex at adhesion plaques (Carlucci 
et al., 2008). FAK has been implicated in regulating multiple signalling pathways 
through its binding to different signalling proteins like paxillin, p130Cas, Src-family 
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PTKs, p85 subunit of phosphatidylinositol 3-kinase (P13-kinase), Shc and Grb2 
proteins. In most cases, binding happens through SH2 and SH3 homology binding 
sites (Schlaepfer et al,. 1999; Jacamo et al., 2007). FAK stimulation of membrane 
signalling proteins assembled to focal adhesion plaques mainly happen due to the 
employment of FAK N-terminal domain. This domain helps in connecting FAK with 
integrins receptors whereby signals will be transmitted downstream triggering FAK 
activity. Both FAK and integrins especially β-integrin participate in signalling 
cascades initiation that transmits signals to downstream targets. FAK-integrins 
association is required for Focal adhesion complex (FAC) establishment within sites 
of focal adhesions. FAC supports FAK performance as docking site for binding to 
several pathways mediator molecules (Ilic et al., 1997; Mitra et al., 2005). Apart 
from that, recruitment of focal adhesion molecules and growth factor receptors such 
as epidermal growth factor receptor and platelet-derived growth factor receptor 
(EGFR and PDGFR respectively) to the site of adhesion further stimulate FAK 
signalling activity (Cohen & Guan, 2005).  
 
FAK involvement in Src activation is not fully understood. It was shown that Src can 
be activated by integrins independent of FAK. That is, α4β1 integrins stimulate Src 
activation, and through this activation motility defects can be restored in FAK-null 
fibroblasts. Src stimulation leads to the activation of p130Cas-associated motility-
promoting signalling pathway. This pathway was also proposed to have a critical 
function in modulating cellular motility, regardless of Src mode of activation. In 
other words, it can regulate cellular motility either by α4β1 integrins or by FAK 
dependent manner (Hanks et al., 2003; Mitra and Schlaepfer, 2006). Figure 1.4 
shows reciprocal roles for both Src and FAK in working as upstream regulators of 
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signalling cascades leading to the establishment of cell motility. FAK as a scaffold 
protein enables it to regulate a range of intracellular signalling molecules namely 
such as Grb7, Rac, PI3K and others. Accordingly, FAK association with these 
proteins modulates its activity to accommodate changes in actin and microtubule 
filaments polymerization, thus directs membrane protrusion and cell polarity toward 
forward movements. 
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Figure 1.4: Downstream Signalling of FAK/Src is highly required for 
lamellipodium orientation leading to the promotion of cell motility (Adapted 
from Hanks et al., 2003). 
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1.3.6 FAK Signalling and Cell Adhesion 
 
FAK plays a central role in regulating various cellular functions of living cells, and 
was implicated in cellular force, stress and contraction. Morphological changes 
happen when cells showed marked decrease in FAK activation. Given that cell 
spreading is crucial for adherent cell survival, cellular death increased as a result of 
cellular cytoskeleton defects in FAK deficient cells (Mitra et al,. 2005).  FAK 
depletion in endothelial cells produced cells that appeared rounded in shape with less 
polarity. In addition, FAK deficient cells showed broad lamellipodia with extended 
protrusions. (Braren et al,. 2006). According to previous report, FAK role in adherent 
cells survival is based on its kinetic role in the formation of adhesive forces. FAK 
activity was thought to be governed by time-dependent adhesive force 
mechanosensing responses, where integrin binding and activation are regulated by 
FAK upregulatory manner (Michael et al,. 2009).  
 
FAK was also implicated in protecting ECM-detached cells from undergoing anoikis, 
and by the virtue of its association with integrin clusters FAK was thought to play a 
regulatory function in cell adhesion strengthening (Haier & Nicolson, 2000). For 
instance, FAK contributed to murine FAK-deficient embryonic stem cells survival 
following detachment from ECM (Ilić et al., 1998). 
 
Fluid flow resistance is a competing shear force against circulating carcinoma cells. 
FAK was proposed to have an important role in the establishment of early stages of 
integrin-mediated adhesion of circulating carcinoma cells. FAK is involved in 
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resisting fluid shear forces, so it exhibits an important function in organ-specific 
formation of distant metastasis (Von Sengbusch et al., 2005).  
 
1.3.7 FAK Involvement in Cell Migration  
 
Cell migration is a coordinated process resultant from rapid dynamic changes of 
actin filaments (Mitra et al., 2005). Cell filopodia are formed by parallel bundles of 
actin, whereas lamellipodia are formed of dense actin meshwork arrangements. Both 
actin structures are involved in guiding cell motility at cell leading edge, and creating 
driving forces that enhance forward movement (Etienne-Manneville, 2004).  
 
FAK plays an important role in regulating cell shape and adhesion, besides, FAK’s 
role in migration was proven both in vivo and in vitro (Hauck et al., 2002; Braren et 
al,. 2006). In previous study, FAK levels increased in migrating cells when wound 
repair assay had been performed. However, FAK-null mice fibroblast cells failed to 
migrate but restored migration capacity following FAK transfection (Owen et al., 
1999; Lipinski et al., 2003). 
 
1.3.8 FAK Involvement in Cancer Invasion and Metastasis 
 
Several studies have proposed that tumour cells that have the tendency to invade 
adjacent tissues and metastasize in vivo usually showed increased levels of FAK 
(Gabarra-Niecko et al., 2003). Metastatic tumour cells have the ability to migrate 
from the place of primary tumour to surrounding or distant tissues. Therefore 
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migration and invasion are both prerequisites for tumour metastasis (Hsia et al., 
2003).  
 
Cancer metastasis requires but not always shared function of matrix 
metalloproteinases (MMPs) for ECM barriers destruction to allow invasion. MMPs 
are localized and stimulated at actin-rich cellular points, where association with 
ECM took place. These contact places which are termed as invadopodia or 
podosomes are constitutively distinct from focal adhesions (Siesser and Hanks, 
2006). 
 
For MMPs-dependent invasion, FAK is involved in MMPs secretion and is known to 
localize at invasive fronts. Invasion can also happen independent of MMPs secretion 
but dependent on FAK to regulate or promote different mechanisms of tumour 
invasions (McLean et al., 2005). 
 
MMP-9 secretion is thought to be stimulated through FAK upstream regulation. 
MMP-9 secretion requires cell attachment to ECM where variety of signalling 
proteins including FAK are of importance (Sein et al,. 2000). According to previous 
study (Wu et al., 2005), MMP-2 activation was thought to happen following the 
stimulation of a cell surface protein known as membrane-type 1 matrix 
metalloproteinase (MT1-MMP) which is implicated in the cleavage of pro-MMP-2 to 
its active form. MT1-MMP stimulation was partially thought to be governed by 
FAK/Src signalling. Increased expressions of MMPs such as MMP-2, MMP-7, 
MMP-9 and MMP-13 have been implicated in various types of cancer (Sternlicht et 
al., 1999; Coussens et al., 2002; Egeblad & Werb, 2002).   
22 
 
 
Figure 1.5 indicates FAK association with cancer development, FAK expression in 
cancer cells (represented by cells in dark colour) was shown to increase dramatically 
along with cancer progression. Normal and benign tumours expressed low amounts 
of FAK, while invasive and metastatic tumours expressed high FAK levels. 
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Figure 1.5: Model of FAK association with cancer invasiveness and metastasis. 
Dark tumour cells represent cells overexpressing FAK (Adapted from Gabarra-
Niecko et al., 2003).  
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1.3.9 FAK Regulates a Dynamic Balance between Cell Survival and Apoptosis 
 
Intracellulalar signalling pathways that regulate and maintain cellular growth and 
survival are governed by shared signalling networks involving growth factor 
receptors, integrins and transmembrane receptors (Gilmore, 2005). It is thought that 
survival or growth signalling pathways interruption can stimulate cell cycle arrest 
and cell execution. FAK has been associated with cell protection from apoptosis and 
prolonging survival of anchorage-dependent cells. Reduced FAK levels in some 
cancer cells resulted in apoptosis (Cance et al., 2000).  
 
Several studies have discussed FAK localization to cell cytoplasm (Sein, 2000; 
Hauck et al., 2002; Hsia et al., 2003; Mon et al., 2006), though the relation between 
FAK translocation or localization to cell nucleus and apoptosis is not yet well 
clarified. In reference to FAK structural functions, FAK N-domain was shown to 
regulate FAK kinase activity and associate with SUMO protein (Parsons et al., 2003; 
Cox et al, 2006). SUMO is a FAK modifier which adapts FAK function through its 
binding to the FAK N-domain, SUMO-FAK association led to FAK localization to 
nuclei (Golubovskaya et al., 2005; Stewart et al., 2002). However, only recently, the 
signals that promote or regulate FAK shuttling in and out of the nucleus were 
limitedly revealed. FAK nuclear localization was also shown to be putatively 
governed by sequences of leucine-rich nuclear export signals (NES). NES signalling, 
mainly NES1 and NES2, instigates nuclear protein translocation to cytoplasm (Terry 
et al., 2007). NES1 sequence is ubiquitously located in the F1 lobe of FAK-N 
domain, whereas NES2 is situated in the kinase domain of FAK. Both signals are 
proposed to enable FAK nucleocytoplasmic shuttling (Ossovskaya et al., 2008). 
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However, since NES2 sequence is not affected by the structural alterations that take 
place in the FAK kinase domain (Lietha et al., 2007) it was thought to exhibit more 
important function in the regulation of FAK nucleocytoplasmic shuttling 
(Ossovskaya et al., 2008). 
 
p53 is a tumour suppressor protein which is considered as one of the most powerful 
apoptosis triggers upon its activation (Reddig and Juliano, 2005). Usually, when cells 
are subjected to stabilized growth conditions p53 is maintained at low levels 
(Vousden, 2002). Cells exposure to stress conditions can enhance p53 stability 
leading to the stimulation of cell cycle targets like p21Cip/WAF1 (p21). p21 is a 
cyclin-dependent kinase inhibitor which is stimulated following the exposure to cell 
death triggers (Oren, 2003; Harris and Levine, 2005). ECM-integrin association was 
shown to maintain cell survival and stimulate p21 degradation with abrogated p53. 
The correlation between cell survival and integrin, p21 and p53 is not completely 
understood (Stromblad et al., 1996; Bao et al., 2002), however could be regulated by 
FAK nucleocytoplasmic shuttling. 
 
FAK has been implicated in p53 inhibition (Golubovskaya et al., 2005; Cance & 
Golubovskaya, 2008). Lim et al. (2008) has discussed FAK role in nuclear 
localization on mouse embryonic fibroblasts cells (MEFs), and suggested that 
nuclear FAK enhanced cell survival through the degradation of p53 by FAK kinase- 
independent manner. It was shown that nuclear FAK N-domain works as a scaffold 
to embrace and stimulate Mdm2 function leading to p53 ubiquitination (Lim et al., 
2008). Mdm2 (Murine double minute-2) is one of the p53 regulatory members which 
regulates p53 level in living cells (Iwakuma and Lozano, 2003).  
